<code id='BD7468DE7B'></code><style id='BD7468DE7B'></style>
    • <acronym id='BD7468DE7B'></acronym>
      <center id='BD7468DE7B'><center id='BD7468DE7B'><tfoot id='BD7468DE7B'></tfoot></center><abbr id='BD7468DE7B'><dir id='BD7468DE7B'><tfoot id='BD7468DE7B'></tfoot><noframes id='BD7468DE7B'>

    • <optgroup id='BD7468DE7B'><strike id='BD7468DE7B'><sup id='BD7468DE7B'></sup></strike><code id='BD7468DE7B'></code></optgroup>
        1. <b id='BD7468DE7B'><label id='BD7468DE7B'><select id='BD7468DE7B'><dt id='BD7468DE7B'><span id='BD7468DE7B'></span></dt></select></label></b><u id='BD7468DE7B'></u>
          <i id='BD7468DE7B'><strike id='BD7468DE7B'><tt id='BD7468DE7B'><pre id='BD7468DE7B'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:9894
          The Amgen booth at ESMO in Madrid.
          The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

          MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

          The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

          advertisement

          “It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Majority of Americans think Trump's Ga. election interference case is serious: POLL
          Majority of Americans think Trump's Ga. election interference case is serious: POLL

          3:10FormerPresidentDonaldTrumpspeaksatthe56thannualSilverElephantGalainColumbia,S.C.,onAug.5,2023.Do

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          ‘Oppenheimer’ and the risks of AI in health care

          APAllgreatstorieshavecomplicatedendings.Butthatdoesn’tmeantheycan’toffersimpleandinstructivelessons.